Skip to main content
OpenTrials

Clinical trial condition

KRAS Positive Patients With Non-small Cell Lung Cancer

Explore clinical trials studying KRAS Positive Patients With Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

KRAS Positive Patients With Non-small Cell Lung Cancer trial results

Completed

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

NCT02283320

Conditions
KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer
Locations
  • Investigative Site: #51 Chandler, Arizona, United States
  • Investigative Site: #30 Goodyear, Arizona, United States
  • Investigative Site: #44 Phoenix, Arizona, United States
  • Investigative Site: #41 Sedona, Arizona, United States
View all 32 locations
View Trial Details

Related conditions